You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

19 Results
Drug
Other Name(s): Columvi®
Sep 2024
Drug
Other Name(s): Epkinly™
Nov 2024
Drug
Other Name(s): Trecondyv®
Jan 2025
Drug
Other Name(s): Asparlas®
Dec 1969
Drug
Other Name(s): Rydapt®
Dec 1969
Drug
Other Name(s): Tecvayli®
Updated
Jul 2025
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Funding:
New Drug Funding Program
    Teclistamab (Outpatient) - Relapsed or Refractory Multiple Myeloma
High Cost Therapy Funding Program
    Teclistamab (Inpatient) - Relapsed or Refractory Multiple Myeloma
Updated
Jul 2025

Pages